Claudia L. Kleinman

Dr Kleinman is a multi-qualified, transdisciplinary researcher who combines the application of molecular biology, computer science, statistics and evolutionary biology to study biological systems on multiple levels — from the molecular level to environmental influences on the genome (i.e., epigenetics).  Her research aims to advance our understanding of cancers and brain disorders by decrypting the fundamental mechanisms regulating gene expression, and their interplay with genetic and epigenetic factors. Her ultimate goal is to map how their complex interactions lead to specific diseases.

in 2021, Science Quebec named her paper in Nature Genetics, Stalled developmental programs at the root of pediatric brain tumors, as one of Quebec’s top 10 research findings of 2020.

Dr Kleinman is a mentor and lecturer in the interdisciplinary Quantitative Life Sciences (QLS) PhD program offered jointly by the McGill faculties of Medicine and Science, and provides key leadership in the Ludmer Centre’s transdisciplinary training activities.

Dr Kleinman completed an MSc-equivalent in Biological Sciences at the Universidad de Buenos Aires (1999) in Argentina, a PhD in Bioinformatics at the Université de Montréal (2010, Dean’s Honor List), and postdoctoral research at the Genome Quebec Innovation Centre (2010-14). She joined McGill and the Lady Davis Research Institute in 2014. She has received awards from Genome Canada, Genome Québec, the, the Canadian Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, Fonds de la recherche en santé Québec, Canadian Institutes of Health Research, the Canadian Cancer Society Research Institute, and currently holds a career award from the Fond de Recherche Québec-Santé.